Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joost G E Janzing

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Drug Discovery Today|June 26, 2024
Machine learning for antidepressant treatment selection in depressionPrehm I M Arnold, Joost G E Janzing, Arjen Hommersom
International Journal of Geriatric Psychiatry|April 27, 2005
Depressive symptom quality and neuropsychological performance in dementiaJoost G E Janzing, Paul Naarding, Paul A T M Eling
International Journal of Geriatric Psychiatry|January 22, 2002
Depression in subjects with and without dementia: a comparison using GMS-AGECATJoost G E Janzing, Chris Hooijer, Martin A van 't Hof, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|September 25, 2009
Apathy is not depression in Huntington's diseasePaul Naarding, Joost G E Janzing, Paul Eling, et al.
Journal of Affective Disorders|February 13, 2022
The Potential of Polygenic Risk Scores to Predict Antidepressant Treatment Response in Major Depression: A Systematic ReviewJulia J Meerman, Sophie E Ter Hark, Joost G E Janzing, et al.
The Pharmacogenomics Journal|January 17, 2019
An economic model of the cost-utility of pre-emptive genetic testing to support pharmacotherapy in patients with major depression in primary careReinier L Sluiter, Joost G E Janzing, Gert Jan van der Wilt, et al.
Journal of Biomedical Informatics|May 17, 2016
Understanding disease processes by partitioned dynamic Bayesian networksMarcos L P Bueno, Arjen Hommersom, Peter J F Lucas, et al.
Psychoneuroendocrinology|April 8, 2014
BDNF in late-life depression: effect of SSRI usage and interaction with childhood abuseAnnemarie van der Meij, Hannie C Comijs, Annemieke Dols, et al.
Psychiatric Genetics|January 7, 2009
Effect of the 5-HTTLPR polymorphism in the serotonin transporter gene on major depressive disorder and related comorbid disordersMaaike Verhagen, Annemarie van der Meij, Joost G E Janzing, et al.
Journal of Affective Disorders|August 16, 2005
A study on symptom profiles of late-life depression: the influence of vascular, degenerative and inflammatory risk-indicatorsPaul Naarding, Robert A Schoevers, Joost G E Janzing, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Drug Discovery Today|June 26, 2024
Machine learning for antidepressant treatment selection in depressionPrehm I M Arnold, Joost G E Janzing, Arjen Hommersom
International Journal of Geriatric Psychiatry|April 27, 2005
Depressive symptom quality and neuropsychological performance in dementiaJoost G E Janzing, Paul Naarding, Paul A T M Eling
International Journal of Geriatric Psychiatry|January 22, 2002
Depression in subjects with and without dementia: a comparison using GMS-AGECATJoost G E Janzing, Chris Hooijer, Martin A van 't Hof, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|September 25, 2009
Apathy is not depression in Huntington's diseasePaul Naarding, Joost G E Janzing, Paul Eling, et al.
Journal of Affective Disorders|February 13, 2022
The Potential of Polygenic Risk Scores to Predict Antidepressant Treatment Response in Major Depression: A Systematic ReviewJulia J Meerman, Sophie E Ter Hark, Joost G E Janzing, et al.
The Pharmacogenomics Journal|January 17, 2019
An economic model of the cost-utility of pre-emptive genetic testing to support pharmacotherapy in patients with major depression in primary careReinier L Sluiter, Joost G E Janzing, Gert Jan van der Wilt, et al.
Journal of Biomedical Informatics|May 17, 2016
Understanding disease processes by partitioned dynamic Bayesian networksMarcos L P Bueno, Arjen Hommersom, Peter J F Lucas, et al.
Psychoneuroendocrinology|April 8, 2014
BDNF in late-life depression: effect of SSRI usage and interaction with childhood abuseAnnemarie van der Meij, Hannie C Comijs, Annemieke Dols, et al.
Psychiatric Genetics|January 7, 2009
Effect of the 5-HTTLPR polymorphism in the serotonin transporter gene on major depressive disorder and related comorbid disordersMaaike Verhagen, Annemarie van der Meij, Joost G E Janzing, et al.
Journal of Affective Disorders|August 16, 2005
A study on symptom profiles of late-life depression: the influence of vascular, degenerative and inflammatory risk-indicatorsPaul Naarding, Robert A Schoevers, Joost G E Janzing, et al.
Pageof 4